2023 - Research.com Medicine in Canada Leader Award
Koon K. Teo mainly focuses on Internal medicine, Cardiology, Randomized controlled trial, Myocardial infarction and Epidemiology. His research in Internal medicine intersects with topics in Diabetes mellitus, Endocrinology and Surgery. As part of one scientific family, Koon K. Teo deals mainly with the area of Cardiology, narrowing it down to issues related to the Ramipril, and often ACE inhibitor.
The Randomized controlled trial study combines topics in areas such as Clinical trial, Conventional PCI, Angioplasty, Quality of life and Physical therapy. His Myocardial infarction study combines topics in areas such as Blood lipids, Cholesterol and Telmisartan. His Epidemiology research is multidisciplinary, incorporating perspectives in Developed country, Prospective cohort study, Cross-sectional study and Population study.
Koon K. Teo focuses on Internal medicine, Cardiology, Myocardial infarction, Heart failure and Disease. Koon K. Teo interconnects Diabetes mellitus and Endocrinology in the investigation of issues within Internal medicine. His study in the field of Coronary artery disease, Revascularization and Stenosis also crosses realms of In patient.
His research on Myocardial infarction frequently links to adjacent areas such as Surgery. His Heart failure research is multidisciplinary, relying on both Physical therapy, Heart disease and Intensive care medicine. The concepts of his Disease study are interwoven with issues in Prospective cohort study, Epidemiology and Risk factor.
His scientific interests lie mostly in Internal medicine, Epidemiology, Prospective cohort study, Cardiology and Disease. His Internal medicine research is multidisciplinary, incorporating elements of Diabetes mellitus and Endocrinology. His Epidemiology research focuses on subjects like Environmental health, which are linked to Developing country.
His Prospective cohort study study combines topics in areas such as Cohort study, Lower risk, Hazard ratio, Socioeconomic status and Cohort. Koon K. Teo interconnects Ramipril, Telmisartan and Post-hoc analysis in the investigation of issues within Cardiology. His Stroke research incorporates elements of Myocardial infarction and Montreal Cognitive Assessment.
His main research concerns Prospective cohort study, Epidemiology, Internal medicine, Environmental health and Cohort study. His Prospective cohort study study combines topics from a wide range of disciplines, such as Incidence, MEDLINE, Disease, Hazard ratio and Low sodium. His Epidemiology study integrates concerns from other disciplines, such as Traditional medicine, Socioeconomic status, Cause of death and Population study.
Koon K. Teo combines subjects such as Endocrinology and Cardiology with his study of Internal medicine. His Cardiology research is multidisciplinary, relying on both Ramipril, Doppler echocardiography and Telmisartan. His study looks at the intersection of Heart failure and topics like Myocardial infarction with Surgery.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Optimal Medical Therapy with or without PCI for Stable Coronary Disease
William E. Boden;Koon K. Teo;Pamela M. Hartigan;David J. Maron.
The New England Journal of Medicine (2007)
Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events
Koon K. Teo;Janice Pogue;Leanne Dyal;Ingrid Copland.
The New England Journal of Medicine (2008)
Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy
Patrice Desvignes-Nickens;Kent Koprowicz;Ruth McBride;Koon Teo.
The New England Journal of Medicine (2011)
Optimal Medical Therapy With or Without Percutaneous Coronary Intervention to Reduce Ischemic Burden Results From the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial Nuclear Substudy
Leslee J. Shaw;Daniel S. Berman;David J. Maron;G. B. John Mancini.
Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial
Johannes F. E. Mann;Roland E Schmieder;Matthew McQueen;Leanne Dyal.
The Lancet (2008)
Prevalence, Awareness, Treatment, and Control of Hypertension in Rural and Urban Communities in High-, Middle-, and Low-Income Countries
Clara K. Chow;Clara K. Chow;Koon K. Teo;Sumathy Rangarajan;Shofiqul Islam.
Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study
Koon K Teo;Stephanie Ounpuu;Steven Hawken;Pandey.
The Lancet (2006)
Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study
Darryl P Leong;Darryl P Leong;Koon K Teo;Koon K Teo;Sumathy Rangarajan;Patricio Lopez-Jaramillo.
The Lancet (2015)
Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE)
Sonia S Anand;Salim Yusuf;Vladmir Vuksan;Sudarshan Devanesen.
The Lancet (2000)
Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial.
S Yusuf;K Teo;C Anderson.
The Lancet (2008)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: